G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	62.79	152.59	139.68	114.75	12.28	14.46
Short-Term Investments	396.9	256.29	173.24	91.2	96.6	105.6
Cash & Short-Term Investments	459.69	408.87	312.92	205.95	108.88	120.06
Cash Growth	43.10%	30.66%	51.94%	89.15%	-9.31%	-4.76%
Accounts Receivable	13.69	17.8	14.78	0.75	5.09	6.09
Other Receivables	0.41	0.16	0.15	0.02	0.03	0.04
Receivables	14.1	17.96	14.93	0.77	5.12	6.13
Inventory	25.82	21.71	22.9	24.64	19.83	16.98
Prepaid Expenses	2.38	2.38	1.41	1.32	2.07	2.97
Total Current Assets	501.98	450.92	352.17	232.69	135.9	146.14
Property, Plant & Equipment	370.93	372.31	375.12	375.15	382.85	389.74
Other Intangible Assets	133.18	133.33	133.89	134.68	135.51	136.11
Long-Term Deferred Tax Assets	0.26	0.26	19.65	37.95	37.59	39.26
Other Long-Term Assets	2.19	2.37	2.27	2.31	0.28	0.48
Total Assets	1,009	959.17	883.1	782.78	692.13	711.73
Accounts Payable	14.67	8.34	4.03	8.97	2.73	3.16
Accrued Expenses	-	17.72	17.34	8.11	1.64	1.56
Current Portion of Leases	0.88	0.88	0.69	-	-	-
Current Income Taxes Payable	7.94	3.1	-	-	-	-
Current Unearned Revenue	95.12	85.23	95.24	71.85	0.45	0.17
Other Current Liabilities	19.2	9.51	1.28	2.82	3.85	3.5
Total Current Liabilities	137.81	124.77	118.57	91.74	8.68	8.39
Long-Term Leases	0.65	0.87	1.29	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	0.2	-	-
Total Liabilities	138.46	125.64	119.86	91.94	8.68	8.39
Common Stock	590	590	556.6	556.6	556.6	556.6
Additional Paid-In Capital	134.24	134.24	134.24	273.33	273.33	273.33
Retained Earnings	145.84	109.3	72.4	-139.09	-146.47	-126.59
Shareholders' Equity	870.07	833.53	763.24	690.84	683.45	703.34
Total Liabilities & Equity	1,009	959.17	883.1	782.78	692.13	711.73
Total Debt	1.53	1.75	1.98	-	-	-
Net Cash (Debt)	458.16	407.13	310.94	205.95	108.88	120.06
Net Cash Growth	43.43%	30.93%	50.98%	89.15%	-9.31%	-4.76%
Net Cash Per Share	7.77	6.89	5.27	3.49	1.85	2.03
Filing Date Shares Outstanding	58.93	59	59	59	59	59
Total Common Shares Outstanding	58.93	59	59	59	59	59
Working Capital	364.17	326.14	233.6	140.95	127.22	137.75
Book Value Per Share	14.77	14.13	12.94	11.71	11.58	11.92
Tangible Book Value	736.89	700.21	629.34	556.16	547.95	567.23
Tangible Book Value Per Share	12.51	11.87	10.67	9.43	9.29	9.61
Land	-	148.59	148.59	148.59	148.59	148.59
Buildings	-	233.58	233.58	233.08	233.39	233.31
Machinery	-	50.77	52.08	55.06	55.32	57.12
Construction In Progress	-	2.39	-	-	-	-
Leasehold Improvements	-	5.33	5.33	5.33	5.33	5.33

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.